Psychedelics – News and Features

LSD changes the communication patterns between regions of the brain, a new study by researchers of the University of Zurich and Yale University shows. The study also provides insights into how mental health disorders develop and how these could be treated.

The use of minute doses of magic mushrooms and truffles containing psychedelic substances could induce a state of unconstrained thought that may produce more new, creative ideas, say study.

COMPASS Pathways, a life sciences company, has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for its psilocybin therapy for treatment-resistant depression. The FDA designates a drug as a Breakthrough Therapy if preliminary clinical evidence shows that it may demonstrate substantial improvement over available therapy.

Smoking cannabis is an effective way of ingesting CBD. However, these days the general public are swaying toward the use of CBD oils. Here we look at the most effective ways of introducing CBD oils into your system for medicinal relief.

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

Chris Timmermann, from The Psychedelic Research group at Imperial College London studies the action of psychedelics on the brain and their potential as therapeutics. This article reviews their research and their implications.

When people take MDMA, the drug popularly known as ecstasy, a rush of serotonin, dopamine, and oxytocin makes people more interested than they would normally be in connecting and sharing with other people. Now, researchers have made the surprising discovery that a species of octopus considered to be asocial responds to MDMA in the same way.

Researchers have figured out precisely why one drug binds to the serotonin receptor 5-HT2BR and activates it to cause heart problems while very similar drugs do not. They've also discovered why a third drug acts like a 5-HT2BR antagonist - it blocks the receptor's activity - while the very well-known similar hallucinogenic drug LSD does not.

Potent psychedelic DMT mimics near-death experience in the brain

Psychologists explore potential benefits of hallucinogens for mental health disorders.